From: Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis
Intervention | |||||||
---|---|---|---|---|---|---|---|
Study | Intervention arm a | Adjuvant therapies b | |||||
 | Type of CHT | N. Cycles | R courses | G-CSF | AI prophylaxis | RTX | Other |
Aviles 2007a | CEOP | 6 | 6 | Discretionary | NR | No | No |
Aviles 2007b | CEOP | 6 | 6 | Not reported | |||
Aviles 2010 | ESHAP | 6 | 6 | To all | No | No | No |
Buske 2009 | CHOP 21 | 4 to 8 | 4 to 8 | Not reported | |||
Coiffier 2002 | CHOP 21 | 8 | 8 | Discretionary | NR | No | No |
Eve 2009 | FC | 8 | 8 | NR | PCP + VZV | No | No |
Forstpointner 2004 | FCM | 4 | 4 | Not reported | |||
Habermann 2006 | CHOP 21 | 6 to 8 | 4 to 5 | Discretionary | NR | No | M |
Herold 2007 | MCP | 8 | 8 | Not reported | |||
Hiddemann 2005 | CHOP 21 | 6 to 8 | 6 to 8 | Not reported | |||
Kaplan 2005 | CHOP 21 | 3 to 6 | 3 to 6 | To all | PCP | Discretionary | M + ART |
Lenz 2005 | CHOP 21 | 6 | 6 | Not reported | |||
Marcus 2005 | CVP | 8 | 8 | Not reported | |||
Pfreundschuh 2008a | CHOP 14 | 6 | 8 | To all | No | No | Pre-O |
Pfreundschuh 2008b | CHOP 14 | 8 | 8 | To all | No | No | Pre-O |
Robak 2010 | FC | 6 | 6 | Discretionary | No | No | No |
van Oers 2006 | CHOP 21 | 3 to 6 | 3 to 6 | Not reported |